Anti-EGFR-based conversion chemotherapy in RAS wildtype colorectal cancer patients: Impact on survival and resection rates.

被引：0
|
作者：
Koch, Christine
Schmidt, Niklas
Winkelmann, Ria
Eichler, Katrin
Hansmann, Martin-Leo
Bechstein, Wolf O.
Pession, Ursula
Zeuzem, Stefan
Trojan, Jorg
Waidmann, Oliver
机构：
[1] Univ Hosp Frankfurt, Dept Gastroenterol & Hepatol, Frankfurt, Germany
[2] Senckenberg Inst Pathol, Frankfurt, Germany
[3] Dept Diagnost & Intervent Radiol, Frankfurt, Germany
[4] Goethe Univ Hosp, Frankfurt, Germany
[5] Univ Hosp Frankfurt, Dept Gen & Visceral Surg, Frankfurt, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15029
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15029
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Anti-EGF Receptor-Based Conversion Chemotherapy in RAS Wild-Type Colorectal Cancer Patients: Impact on Survival and Resection Rates
    Koch, Christine
    Schmidt, Niklas
    Winkelmann, Ria
    Eichler, Katrin
    Pession, Ursula
    Bechstein, Wolf Otto
    Zeuzem, Stefan
    Waidmann, Oliver
    Trojan, Joerg
    DIGESTION, 2018, 98 (04) : 263 - 269
  • [2] Rechallenge with anti-EGFR-based therapy in metastatic colorectal cancer: Impact of intervening time interval and prior anti-EGFR response.
    Liu, Xiaochun
    George, Goldy C.
    Tsimberidou, Apostolia Maria
    Naing, Aung
    Wheler, Jennifer J.
    Kopetz, Scott
    Fu, Siqing
    Piha-Paul, Sarina Anne
    Eng, Cathy
    Falchook, Gerald Steven
    Janku, Filip
    Garrett, Chris R.
    Karp, Daniel D.
    Kurzrock, Razelle
    Zinner, Ralph
    Raghav, Kanwal Pratap Singh
    Subbiah, Vivek
    Meric-Bernstam, Funda
    Hong, David S.
    Overman, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Negative Ultraselection of Patients With RAS/BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti-EGFR-Based Therapy
    Randon, Giovanni
    Maddalena, Giulia
    Germani, Marco Maria
    Pircher, Chiara Carlotta
    Manca, Paolo
    Bergamo, Francesca
    Giordano, Mirella
    Sposetti, Caterina
    Montagna, Aldo
    Vetere, Guglielmo
    Zambelli, Luca
    Rasola, Cosimo
    Boccaccino, Alessandra
    Pagani, Filippo
    Ambrosini, Margherita
    Massafra, Marco
    Fontanini, Gabriella
    Milione, Massimo
    Fassan, Matteo
    Cremolini, Chiara
    Lonardi, Sara
    Pietrantonio, Filippo
    JCO PRECISION ONCOLOGY, 2022, 6
  • [4] Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study
    Fuca, Giovanni
    Raimondi, Alessandra
    Prisciandaro, Michele
    Lonardi, Sara
    Cremolini, Chiara
    Ratti, Margherita
    Clavarezza, Matteo
    Murialdo, Roberto
    Sartore-Bianchi, Andrea
    Smiroldo, Valeria
    Berenato, Rosa
    Racca, Patrizia
    Bergamo, Francesca
    Corallo, Salvatore
    Di Bartolomeo, Maria
    de Braud, Filippo
    Morano, Federica
    Pietrantonio, Filippo
    ONCOLOGIST, 2022, 27 (01): : E29 - E36
  • [5] The clinical significance of the gut microbiota in RAS wildtype metastatic colorectal cancer patients treated with anti-EGFR monoclonal antibodies in combination with chemotherapy - preliminary results
    Lewandowski, T.
    Stelmasiak, P.
    Nska, J. Stefa
    Wolinowska, R.
    Bobrowska, B.
    Laskowska, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S185 - S185
  • [6] Plasma Dynamics of RAS/RAF Mutations in Patients With Metastatic Colorectal Cancer Receiving Chemotherapy and Anti-EGFR Treatment
    Thomsen, Caroline Brenner
    Andersen, Rikke Fredslund
    Lindebjerg, Jan
    Hansen, Torben Frostrup
    Jensen, Lars Henrik
    Jakobsen, Anders
    CLINICAL COLORECTAL CANCER, 2019, 18 (01) : 28 - +
  • [7] The Impact of Sidedness on the Efficacy of Anti-EGFR-Based First-Line Chemotherapy in Advanced Colorectal Cancer Patients in Real-Life Setting-A Nation-Wide Retrospective Analysis (RACER)
    Potocki, Pawel Michal
    Wisniowski, Rafal
    Haus, Dominik
    Chowaniec, Zbyszko
    Kozaczka, Maciej
    Kustra, Magdalena
    Samborska-Plewicka, Marzenna
    Szweda, Marcin
    Starzyczny-Slota, Danuta
    Michalik, Magdalena
    Slomian, Grzegorz
    Lebiedzinska, Aneta
    Jonak-Olczyk, Natalia
    Laszewska-Krainska, Natalia
    Adamowicz, Krzysztof
    Kolenda, Piotr
    Drosik-Kwasniewska, Anna
    Szwiec, Marek
    Dziura, Robert
    Czech, Justyna
    Dabrowska, Maria
    Nowakowska-Zajdel, Ewa
    Klank-Sokolowska, Ewa
    Konopka, Kamil
    Kwinta, Lukasz
    Dobrzanska, Jolanta
    Wysocki, Piotr J.
    CANCERS, 2023, 15 (17)
  • [8] Resistance mechanisms to anti-EGFR therapy in RAS/RAF wildtype colorectal cancer varies by regimen and line of therapy.
    Parseghian, Christine Megerdichian
    Sun, Ryan
    Woods, Melanie Nicole
    Napolitano, Stefania
    Alshenaifi, Jumanah
    Willis, Jason
    Nunez, ShaKayla Kentel
    Sorokin, Alexey
    Marie, Preeti Kanikarla
    Raghav, Kanwal Pratap Singh
    Morris, Van K.
    Shen, John Paul Y. C.
    Sanchez, Eduardo Vilar
    Rehn, Marko
    Ang, Agnes
    Troiani, Teresa
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] The impact of adjuvant chemotherapy timing on overall survival following colorectal cancer resection
    Nachiappan, S.
    Askari, A.
    Mamidanna, R.
    Munasinghe, A.
    Currie, A.
    Stebbing, J.
    Faiz, O.
    EJSO, 2015, 41 (12): : 1636 - 1644
  • [10] Impact of timing of initiation of adjuvant chemotherapy on survival after resection of colorectal cancer
    Ahmad, I.
    Anan, G.
    Alvi, R.
    Haider, K.
    Sami, A.
    Yadav, S.
    Arnold, F.
    McLeann, L.
    Popkin, S.
    Ahmed, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345